Is Bombay Super Hyb overvalued or undervalued?

As of 11 September 2025, the valuation grade for Bombay Super Hyb has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently deemed overvalued based on its high PE ratio of 51.81, an EV to EBITDA of 44.05, and a PEG ratio of 2.42. In comparison, peers such as Jain Irrigation, with a PE ratio of 119.78, and Indo US Bio-Tech, which is fairly valued with a PE of 16.9, highlight the stark contrast in valuation metrics within the industry.
Bombay Super Hyb's financial ratios suggest that it is not only overvalued but also carries a higher risk compared to its peers. The company has underperformed the Sensex significantly over the past year, with a return of -26.88% compared to the Sensex's modest gain of 0.35%. This performance, coupled with its very expensive valuation, reinforces the conclusion that Bombay Super Hyb is currently overvalued in the market.